181365-26-4 Usage
Uses
Used in Organic Synthesis:
1-(TERT-BUTOXYCARBONYL)INDOLE-3-BORONIC ACID is used as a building block in organic synthesis for the creation of biologically active molecules. Its unique reactivity and the presence of the indole ring make it a valuable component in the synthesis of complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(TERT-BUTOXYCARBONYL)INDOLE-3-BORONIC ACID is utilized as a tool in drug development. Its potential pharmacological properties and the ability to modify its structure through the removal of the protective tert-butoxycarbonyl group make it instrumental in the design and synthesis of new drugs.
Used in Agrochemical Development:
1-(TERT-BUTOXYCARBONYL)INDOLE-3-BORONIC ACID also finds application in the agrochemical sector, where it serves as a key intermediate in the synthesis of bioactive compounds for use in crop protection and other agricultural applications. Its versatility in chemical reactions contributes to the development of novel agrochemicals with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 181365-26-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,3,6 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 181365-26:
(8*1)+(7*8)+(6*1)+(5*3)+(4*6)+(3*5)+(2*2)+(1*6)=134
134 % 10 = 4
So 181365-26-4 is a valid CAS Registry Number.
181365-26-4Relevant articles and documents
Pyrimidine derivatives Anaplastic lymphoma kinase inhibitors
-
, (2017/07/23)
The invention belongs to the field of a medical technology and specifically relates to a pyrimidine derivative type anaplastic lymphoma kinase inhibitor as shown in the general formula (I) or its stereisomer, or its pharmaceutically acceptable salt, ester or solvate, wherein R1, R2, R3, R4, R5 and A ring are as defined in the specification. The invention also relates to a preparation method of the compounds, a pharmaceutic preparation and a pharmaceutical composition containing the compounds and an application of the compound or its stereisomer, or its pharmaceutically acceptable salt, ester or solvate in the preparation of medicines for treating and/or preventing diseases related to anaplastic lymphoma kinase-mediated cancer.
TREATMENT OF NEURODEGENERATIVE DISEASES USING INDATRALINE ANALOGS
-
Page/Page column 102, (2009/04/25)
Methods and compositions useful in the treatment or prevention of synucleinopathies, such as Parkinson''s disease, diffuse Lewy body disease, and multiple system atrophy, or other neurodegenerative diseases (e.g., amyotrophic lateral sclerosis, Huntington''s disease, and Alzheimer''s disease) are provided. The treatment including administering to a subject an indatraline derivative that inhibits the aggregation of a-synuclein.
